Over the past decade, however, a wave of technological advances has begun to expand the druggable proteome. These include covalent inhibitors (such as sotorasib), chemical proteomics, and AI-enabled ...
OpenAI's $110B funding includes AWS as the exclusive third-party distributor for the Frontier agent platform, introducing an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results